Related Experiment Video
Updated: Mar 21, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
20.0K
Practical Management of Castleman's Disease
Musa Fares Alzahrani1, Mansoor Radwi, Heather A Leitch
1Hematology Program, St. Paul's Hospital, University of British Columbia, Vancouver, B.C., Canada.
Acta Haematologica
|May 11, 2016
Summary
Castleman's disease (CD) is a rare disorder. Multicentric CD (MCD) is linked to HIV, IL-6, and HHV-8, with new treatments emerging for HIV-negative patients.
Area of Science:
- Hematology
- Immunology
- Virology
Background:
- Castleman's disease (CD) is a rare lymphoproliferative disorder.
- Multicentric Castleman's disease (MCD) often co-occurs with HIV infection.
- Interleukin-6 (IL-6) and human herpesvirus-8 (HHV-8) are key in MCD pathogenesis.
Purpose of the Study:
- To review the pathogenesis of MCD.
- To discuss emerging therapeutic strategies for MCD.
- To highlight the need for a stratified management approach.
Main Methods:
- Literature review of MCD pathogenesis and treatment.
- Analysis of the roles of IL-6 and HHV-8 in MCD.
- Evaluation of current and novel therapeutic options.
Main Results:
- IL-6 and HHV-8 are central to MCD development.
- IL-6 and IL-6 receptor inhibitors show promise for HIV-negative MCD.
- Despite advances, MCD prognosis remains challenging.
Conclusions:
- MCD pathogenesis involves IL-6 and HHV-8.
- Targeted therapies, especially IL-6 inhibitors, offer new hope for HIV-negative MCD.
- A tailored, stratified approach is crucial for optimal MCD management.
More Related Videos
Related Concept Videos
01:24Cystic Fibrosis: Management
612
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
612
01:28Chronic Kidney Disease III: Interprofessional Care
595
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
595
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
631
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
631
01:29Cardiomyopathy V: Interprofessional Care
605
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
605
01:21Rheumatic Heart Disease III: Medical Management
480
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
480
01:29Chronic Pancreatitis II: Collaborative Care
467
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
467